Mouse monoclonal anti-progesterone IgG1 antibody designated DB3 has an anti-fertility effect when injected into female mice shortly after mating. In BALB/c mice, pregnancy is blocked, probably as a result of progesterone withdrawal with inhibition of implantation. Rabbit polyclonal anti-idiotype raised against DB3 has been used in an indirect immunofluorescence method on frozen tissue sections to demonstrate the presence of DB3 on the surface of uterine luminal and glandular epithelia before implantation. DB3 was only detectable 30\p=n-\60h after a single parenteral injection (9 nmol antibody per mouse i.p. or i.v. at 32 h post coitum). Immunolocalization was both pregnancy-dependent and anti-progesterone antibody-specific, as it was not seen in pseudopregnant mice or mice treated with P3 (mouse myeloma IgG1 protein, using polyclonal anti-P3 anti-idiotype as a probe) or saline. The immunofluorescent reaction was completely blocked by addition of DB3 idiotype in vitro. The results indicate that anti-progesterone antibody binds to an antigen associated with luminal and glandular epithelia which may locally inhibit the uterine uptake of progesterone and disrupt the process of implantation.
Introduction
Progesterone is the major hormone required for the establishment and maintenance of pregnancy; antibodies to progesterone are of particular interest as agents which may not only further our understanding of the influence of the steroid on early embryonic development, but also highlight a potential mechanism for the immunological prevention of pregnancy. Studies with monoclonal anti-progesterone antibodies have revealed a brief period in mouse embryonic development when passive immunization against progesterone blocks subsequent cleavage and implantation (Wright et ai, 1982; Heap et ai, 1984; Wang et al., 1984; Rider et ai, 1987) . The effect is probably the result of antibody sequestration of progesterone, since the effect in BALB/c mice can be reversed by the administration of high doses of progesterone provided the hormone is given within 48 h after antibody (Rider et al., 1985) . Similar studies with rats (Phillips et al., 1988) and ferrets (Rider & Heap, 1986) have demonstrated that anti-progesterone antibody treatment will also block the establishment of pregnancy in these species.
Although the anti-implantation efficacy of 5 monoclonal antibodies (mAbs) to progesterone studied was similar, with a 50% effective dose within the range 0-8-2-0 nmol (Ellis et ai, 1988) , one of those, designated DB3, is the mAb which has been the most extensively studied. A single injec¬ tion of DB3 at 8 or 32 h after mating prevents implantation in BALB/c mice whether given by the intraperitoneal (i.p.) or intravenous (i.v.) route. However, the mechanisms by which the antibody blocks pregnancy are not completely defined, although its localization within tissues of the host animal might provide clues to its site of action.
Anti-idiotypes are antibodies directed against the antigen-combining sites of other antibodies. Rabbit polyclonal anti-idiotype made against DB3 has been used to demonstrate anti-idiotypic manipulation of the immune response and can both immunize mice against progesterone and prime for a secondary anti-progesterone response leading to a significant reduction of subsequent pregnancy rate in most immunized animals (M.-W. Wang, R. B. Heap & M. J. Taussig, unpublished data) . Anti-idiotypes can also be used as probes to detect endogenous or administered isologous immunoglobulin and can substantially reduce cross-reactive binding since their reaction is highly specific. Wang et al. (1988) described a method for the localization of administered antibodies by use of specific anti-idiotypes: DB3 was reported to be localized within the mouse uterus and to a lesser degree on the serosal surface of the oviduct 36 h after antibody injection. In the present study we have further used an anti-DB3 idiotype in conjunction with indirect immunofluorescence to study the kinetics of antibody localization after parenteral administration.
Materials and Methods
Animals. Mature virgin female BALB/c mice, 10-12 weeks of age, were used from the Institute's stocks and housed in a light-(14 h light: 10 h dark; lights off at 20:00 h) and temperature-(22°C) controlled room. They were fed a standard diet (Labsure; Christopher Hill Group, Poole, Dorset, UK). Females were caged with males of the same strain overnight and examined the next morning for the presence of vaginal plugs (Day 1 of pregnancy). Pseudopregnancy was achieved by placing females with males which had been surgically vasectomized at least 3 weeks previously. Mating was assumed to have taken place at 0200 h, time 0 (Bronson et al., 1966) . The vaginal plug smear of pseudopregnant mice was examined on Day I by light microscopy to exclude the presence of spermatozoa from mating with vasectomized males. In some mice, the uterotubal junction of both sides was surgically ligated (double suture) at laparotomy 2 weeks before mating; sham animals were treated in the same way except that sutures were not applied to the junction.
Antibodies. The mAb to progesterone (DB3) was produced in BALB/c mice and characterized as described pre¬ viously (Wright et al., 1982; Wang et ai, 1984) . The BALB/c mouse myeloma protein P3 was derived from ascites of the plasmacytoma MOPC 21 (Potter, 1977) . Both antibodies are of the IgGl isotype. The F(ab')2 fragment of DB3 was prepared by digestion with pepsin (Worthington, London, UK) in 0-2 M-acetate buffer, pH 4, at a pepsin:IgG ratio of 1:50 (w/w) (IgG at 5 mg/ml), for 40 h at 37°C (Mason & Williams, 1980) . The digest was neutralized and F(ab')2 was separated by gel filtration on Sephadex G 200 (Taussig et ai, 1986 ). Mice were given single i.p. or i.v. injections of DB3 or P3 in saline (up to 250 µ ) at 32 h post coitum (p.c.), the doses being 9 nmol (1-35 mg) of DB3 whole IgG or 1-35 mg of DB3 F(ab')2 and 1-35 mg of P3. Control females received an equivalent volume of saline alone. Autopsies were carried out at various time-points after the treatment and the number of corpora lutea (CL) recorded.
Anti-idiotypic antibodies to DB3 were raised in a rabbit and to P3 in a sheep. The anti-DB3-idiotype and anti-P3idiotype were affinity purified, and assayed using radioimmunoassay (RIA) and enzyme-linked immunoabsorbent assay (ELISA) following methods described elsewhere (Taussig et al., 1986; Wang et ai, 1988) .
Immunohistology. Uteri and oviducts removed from mice at autopsy (2-72 h after injection) were immediately snap-frozen in Hank's Balanced Salts Solution (HBSS; Flow Laboratories, Irvine, UK) at -70°C and longitudinally sectioned through the length of oviduct and uterus in a cryostat microtome at 8 µ . Sections were air-dried and fixed in cold acetone for 5 min before addition of anti-idiotypes. Sections were treated with PBS containing 2% normal goat serum (NGS, for anti-DB3-idiotype staining) or normal rabbit serum (NRS, for anti-P3-idiotype staining) to block non-specific binding. They were then reacted with relevant anti-idiotypes (50 µg/ml). All incubations were for 30 min at room temperature and the reagents diluted in phosphate-buffered saline (PBS). Control sections were reacted with anti-DB3-idiotype (100µg/ml) in the presence of free DB3 idiotype (100µg/ml) against which the anti-idiotype was made. Positive controls were reacted with rabbit or sheep anti-mouse immunoglobulin G (IgG, affinity purified) at 50 µg/ml. After extensive washing with PBS, the specimens were incubated with fluorescein isothiocyanate (FITC)conjugated goat anti-rabbit IgG (whole antibody or F(ab')2 fragment from Sigma, St Louis, MO, USA) for anti-DB3idiotype and rabbit anti-mouse IgG or FITC-conjugated rabbit anti-sheep IgG (Vector Laboratories, Peterborough, UK) for anti-P3-idiotype and sheep anti-mouse IgG. Both conjugated antisera were affinity purified. The IgG was used at 1:40 dilution and the F(ab')2 fragment was used at 1:20 dilution. Sections were then wet-mounted in PBS for examination on a Leitz Diavert microscope. Two or 3 sections of each side of the reproductive tract were used for each animal. The entire length of the uterus and regions of the oviduct such as isthmus and ampulla were thus examined.
Photographs were taken on XP1 (1600 ASA) films. FITC fluorescence intensity was scored on a qualitative scale of -(none) to + + + + (intense) by two independent observers.
Results
Using an anti-DB3-idiotype, anti-progesterone antibody (DB3) was detected on the epithelial surface of the uterine lumen and glands (Figs la & b) between 30 and 60 h after DB3 injection (i.e. 62-92 h p.c.), with maximal activity occurring around 36 h after injection (Group 6, Table 1 ). The reaction was weaker if: (i) the F(ab')2 fragment of DB3 was used for i.p. injection (Group 6b; Table  1 ); (ii) the uteri were flushed through with 1 ml HBSS before histological processing (Group 6c); or (iii) DB3 was given intravenously instead of intraperitoneally (Group 6a vs 6d; Table 1 ). Localiza¬ tion of DB3 in the uterus was pregnancy-specific as it was not seen in pseudopregnant animals (Group 6e, Table 1 ; Fig. lc ). Immunofluorescent reaction of the uterine epithelia was completely blocked by addition of DB3-idiotype to anti-DB3-idiotype in vitro (Fig. Id) . Double-suture ligation of the uterotubal junction also prevented visualization of DB3 in the uterus ( Table 2) .
The detection of DB3 in the uterine stroma was obvious in pregnant, but not in pseudopregnant (or control) mice by the use of FITC-propidium iodide double-fluorescence technique. The cellular localization of DB3 was diffuse and difficult to depict by monochrome photography.
All samples of uterine tissue labelled strongly for the presence of mouse IgG by rabbit or sheep anti-mlg ( Fig. le) whereas samples from saline-treated mice always appeared to be negative for both anti-idiotypes (Groups 3e, 4f, 6h, 7g, Table 1 ). With an anti-P3-idiotype, P3 was not detec¬ table in uterine tissue from P3-treated animals (Groups 6f, g, Table 1 ; Fig. If ) but could be detected in other sites such as peritoneal exúdate cells or mononuclear cells in the white pulp of spleen (on the cell membrane surface), liver (granules of Kupffer cells), and kidney glomerular basement membrane as previously reported .
To exclude the possibility that DB3 had a non-specific effect on uterine permeability to IgGl molecules, two groups of mice (4 in each) were injected with a mixture of DB3 and P3. In the first group 9 nmol DB3 and 9 nmol P3 were injected in 250 µ saline i.p. and autopsies performed 36 h after injection. The second group received half this dose (9 nmol total IgGl) in 250 µ saline. P3 could not be visualized in the uterus by anti-P3-idiotype in either group whereas DB3 could still be detected by anti-DB3-idiotype. In addition, sections from saline-treated mice (36 h after injection) were reacted with DB3 or P3 in vitro at various dilutions, followed by relevant anti-idiotypes and FITC-conjugated reagents. The results were negative (Table 3) .
Fluorescent labelling also occurred in the oviduct of pregnant or pseudopregnant mice which had been injected intraperitoneally with DB3 or P3, but the reaction was weak and only appeared on the surface of the oviducal serosa. Samples from various time-points (2-72 h) after treatment were examined. Immunofluorescence of the oviduct serosa was seen in most animals injected i.p. from 24 to 48 h and started to disappear around 72 h, although the detection of P3 in the oviduct was slightly earlier (12 h) than DB3; there was no significant immunofluorescent difference for either anti-idiotype in pregnant and pseudopregnant mice whereas anti-mouse Ig always showed a positive immunofluorescent labelling and saline-treated control animals were negative when reacted with anti-DB3-idiotype or anti-P3-idiotype (Table 4 ).
Discussion
Monoclonal anti-progesterone antibodies can be used to study the mechanisms through which the hormone exerts its essential role in the establishment and maintenance of pregnancy. The efficacy of an anti-progesterone antibody, DB3, in blocking implantation in BALB/c mice at the doses used in the present experiments is well documented Ellis et al., 1988) . Although there is evidence indicating that progesterone withdrawal is essential in the action of anti-progesterone Table 1 . Localization of différent parenterally administered antibodies in uterine tissues of BALB/c mice (anti-progesterone antibody (DB3) or BALB/c mouse myeloma protein (P3) was injected intraperito¬ neally (i.p.) or intravenously (i.v.) 32 h after mating and antibodies were localized by anti-idiotypic antibodies raised against DB3 or P3, and mouse immunoglobulins by antisera raised against mouse immunoglobulins) 12-5 + 1-0 11-6 ± 10 90 ± 1-2 10-2 ± 0-7 11-5 ±0-8 8-2 ± 0-9 9-8 ± 1-4 8-4 + 11 14-9 + 0-9 11-3 ± 11 9-7 ± 1-0 10-2 ± 0-7 120 ± 20 11-8 ± 10 90 ± 0-9 12-2 ± 1-3 11-5 ± 1-0 10-5 ± 1-4 11-9 ±0-6 8-3 ± 0-4 10 9 ±0-6 9-3 ± 0-7 10 3 ± 0-9 11-5 ±0-6 11-3 ±0-3 10-0 ± 10 10-0 + 0-8 12-6 + 0-5 10-9 ± 1-4 10-3 ± 0-9 100 ± 10 11-2 + 0-8 9-3 ± 0-7 8-8 ± 0-6 10-7 ± 0-7 9-8 ± 0-7 9-3 + 0-7 8-5 + 0-4 11-2 + 1-1 10-2 ± 0-3 9-2 + 0-7 tStaining could be blocked by addition of free DB3, but not by addition of free P3. ÍThe uteri were flushed through before histological processing. §Number borderline/number negative. •Rabbit anti-DB3-idiotype and anti-mouse Ig for DB3 and saline treated mice; sheep anti-P3-idiotype and antimouse Ig for P3 treated mice. Goat anti-rabbit or rabbit anti-sheep FITC conjugated IgG as second antibodies respectively. FITC fluorescence was assessed on a qualitative scale: -(negative); + (borderline); + (weakly posi¬ tive); + + (positive); + + + (strongly positive) and + + + + (very strongly positive). Antibodies were injected into pregnant or pseudopregnant mice 32 h p.c. The control animals received an equal volume of saline. Animals were killed 36 h after treatment; the oviduct tissue was kept at -70°C and frozen-sectioned for indirect immunofluorescence microscopy examinations by use of respective purified anti-idiotypes. 'Results shown as no. weakly positive/no. examined for anti-idiotype reaction; no. positive/ no. examined for anti-mouse Ig reaction.
"Borderline staining.
antibody against pregnancy (Rider et al., 1985) , the mechanisms whereby DB3 achieves pregnancy block are not completely understood. The results presented here show that DB3 specifically targets to uterine tissue from 30 to 60 h after injection as demonstrated by its anti-idiotypic antiserum and thus confirm and extend earlier findings . We have been able to determine that this is a pregnancy-dependent effect not seen in pseudopregnant animals. In addition, another The route of administration of DB3 appears to make a difference because i.p. injection resulted in greater uterine tissue fluorescence than that observed following i.v. injection. Ligation of the uterotubal junction of the oviduct eliminated the reaction for anti-DB3-idiotype 36 h after injec¬ tion, indicating that a significant proportion of the DB3 injected intraperitoneally entered the uterine lumen from the peritoneal fluid via the oviduct. These findings are consistent with an earlier study in which oviducal intraluminal transport of immunoglobulins was observed in mice following intraperitoneal administration of monoclonal antibodies to spermatozoa (Saling et al., 1986) .
In the mouse, uterine and oviducal epithelial cells are responsible for the transport of immuno¬ globulins into the lumen of the female reproductive tract in early pregnancy (Parr & Parr, 1986 ). In the present study sections of oviduct at various levels (ampulla, isthmus) remained negative for anti-DB3-idiotype immunofluorescent staining, indicating that DB3 was not sequestered by the oviduct but rather specifically retained by uterine tissues. The oviduct probably only served as a passage for DB3 from the peritoneal cavity into the uterus. The observations would seem to exclude the possibility that DB3 is associated directly with the classical progesterone receptor as the latter occurs in oviduct as well as uterus (Perrot-Apptanat et al., 1985) and its localization is nuclear (Gase & Baulieu, 1986) . The predominant localization of DB3 antibody on the cell surface of uterine luminal and glandular epithelia suggests that DB3 recognizes a transiently expressed determinant which is associated with pregnancy. Cross-linking fixatives such as Bouin's fluid destroyed the ability of anti-DB3-idiotype to visualize DB3 in the uterus, suggesting that the antigenic determinant recognized by anti-DB3-idiotype is labile.
At the time ofdecidualization, the movement of IgG into the uterine lumen of the rat is regulated by progesterone and may be important for the successful implantation of blastocysts (Stern & Wira, 1986) . The possibility that DB3 alters uterine permeability to IgGl immunoglobulin was, however, excluded by simultaneously injecting both DB3 and P3; only DB3 could be visualized in the uterus by use of anti-DB3-idiotype, thus verifying the selective localization of DB3 in the uterus.
In the oviduct a weak immunofluorescence was found with both anti-idiotypes, but was only present on the oviducal serosa. It is probable that after an i.p. injection the antibody was mixed with peritoneal fluid and remained in the peritoneal cavity for some time and interacted with the oviducal serosa causing a weak binding, which could be easily blocked by preabsorption of either free idiotype (data not shown). Therefore, this localization was probably caused by non-specific anti-IgGl binding activity of the anti-idiotypes.
Our observations lead us to conclude that anti-progesterone mAb DB3 specifically targets to uterine tissue. There are two possible explanations for these results. Firstly, DB3 may enter the uterus and bind to an unknown antigen expressed transiently on the uterine epithelia between Days 3 and 4 of pregnancy (before implantation). Other groups have reported that monoclonal anti¬ bodies of defined specificity occasionally detect other antigenic determinants and examples of this phenomenon have been reviewed elsewhere (Lane & Koprowski, 1982; Goding, 1986) . Secondly, and perhaps more obviously, DB3 may enter the uterus and bind to progesterone on the uterine epithelial surface. It is possible that progesterone is associated with a carrier molecule (e.g. a progesterone-binding protein such as uteroglobin in rabbits; Bochskanl et al., 1988) . The idea that DB3 can detect progesterone bound to a carrier molecule receives support from a preliminary experiment in which a high affinity progesterone-binding protein purified from the coypu plasma (Myocastor coypus: Heap et al., 1981) was saturated by free progesterone and then reacted with DB3 or P3. Bound DB3 (but not P3) was detectable in a dose-dependent manner by use of either anti-DB3-idiotype or anti-mouse Ig (M.-W. Wang, M. J. Taussig & R. B. Heap, unpublished data). Binding of DB3 to a progesterone transport protein at the epithelial cell surface may be a mechanism by which DB3 prevents uptake of progesterone, leading to inhibition of pregnancy.
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